Discover Great Companies Discover Great Clients
Popularity  5.1万   |   Followers  2   |   Likes  16   |   Feedback  1 Claim this company

New drug R&D services and API production

No.560 Shanghai Popularity Ranking No.201 Pudong New District No.1 Yao Products Chemistry No.1 Chromatography No.1 Ye Xiang Se Pu Systems No.2 Pharmaceutical APIs No.2 Chemistry APIs No.2 APIs No.3 Generic Drugs No.4 Hua He Products Design Compositing No.4 Zhong Jian Ti No.5 Pharmaceuticals Engineering No.6 Chemical Raw Materials No.10 Yi Yao Xin Yao 技术先进型服务企业 高新技术企业 专利示范企业 市级专精特新中小企业 省级高新技术企业 市级高新技术企业
More

Company Overview

  • Nature: Listed Company Size: 1000-4999 employees Founded: 19年
  • Industry: Pharmaceutical/Biotechnology 、 Academic/Scientific Research
  • Full name: Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #560 in Shanghai by popularity Ranked #1 in Shanghai Yao Products Chemistry Company by popularity Ranked #1 in Shanghai Chromatography Company by popularity Ranked #1 in Shanghai Ye Xiang Se Pu Systems Company by popularity Ranked #2 in Shanghai Pharmaceutical APIs Company by popularity
  • Honors: 技术先进型服务企业 高新技术企业 According to algorithm
  • Salary: 45.1% of positions earn 20-50K, In 2026 vs last yeargrew by 27%.。Master's salary: ¥28.2K, Doctorate salary: ¥32.7K.
  • R&D: "Other (R&D and Technical)" demand: 39.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 37.6%, "Scientific Research": 36.8%。
  • Recruiting: In 2026 vs 2025grew by 27%. Demand for highly educated talent: Master's: 27, Doctorate: 15.
  • Requirement: Education: 本科 leads with 42.9%. Experience: 不限 leads with 36.3%.
  • Region: Distributed across 2 regions, 上海: 72.5%, 成都: 26.4%, 天津: 0.5%, 广州: 0.5%.

About the Company

[Summary] New drug R&D services and API production

Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. is a rapidly developing enterprise specializing in new drug R&D services and API production. Since its establishment in December 2007, the company has been driven by technological innovation, aiming to create a distinctive "intelligence-based" innovative enterprise. It actively engages in comprehensive cooperation with clients and business partners, striving to become a leading enterprise in new drug creation services, API process innovation research, production, and sales.
Hongbo Pharmaceutical is headquartered in the eastern area of Zhangjiang High-Tech Industrial Park, Pudong New Area, Shanghai, with nearly 22,000 square meters of office space, laboratories, and advanced equipment. Since its inception, the company has focused on creating a safe, comfortable, and scientific working environment for employees. It currently boasts various experimental and testing equipment, including NMR, SFC, HPLC, chiral-HPLC, LC-MS, LC-MS/MS (API4000), IR, UV, GC, GC-MS, normal/reverse-phase preparative chromatography, microwave synthesizers, and parallel synthesizers. As a high-tech enterprise, this high-quality research environment ensures the efficient operation and scientific achievements of Hongbo Pharmaceutical's R&D departments.
Hongbo Zhiyuan (Kaiyuan) Pharmaceutical, located in Kaiyuan City, Liaoning Province, serves as the production base. Covering an area of 150,000 square meters, it features plants, facilities, and testing systems that comply with current GMP standards. It primarily focuses on the R&D, production, and sales of high-end chemical APIs and intermediates at the forefront of international trends. Current products include ticagrelor, peramivir, velpatasvir, sofosbuvir, etc. The base has obtained the EU COS certificate and multiple international high-end certifications, and maintains long-term cooperation with several well-known foreign enterprises such as Pfizer (USA), Abbott (USA), Novartis (Switzerland), Sanofi (France), Chemo (Italy), TEVA (Israel), Dr. Reddy's and Cipla (India), demonstrating immense potential for sustained growth.
The company currently employs nearly 850 people. In 2010, it was recognized as a technology-advanced service enterprise, and from 2014 to 2017, it was consecutively rated as a high-tech enterprise. Dr. Chen Ping, CEO, and Dr. Cai Zhenwei, Senior Vice President of Medicinal Chemistry, are both seasoned experts in medicinal chemistry. For their contributions to a class of anti-cancer new drugs, they received the Thomas Edison New Drug Invention Patent Award in the United States in 2008 and 2011, respectively.
Hongbo Pharmaceutical emphasizes a corporate culture of "science-oriented and continuous innovation," which is integrated into its management systems, talent development, and team building. In addition to focusing on scientific and experimental skills development, the company organizes annual parties, quality development training, group trips, birthday celebrations, and various cultural and sports activities. It also establishes a special fund for team building. These activities not only provide employees with vertical and horizontal communication opportunities but also enhance their sense of belonging and teamwork awareness.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Hongbo Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Hongbo Pharmaceutical How Fast Is Hiring Growing? (99 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 22%
  • 2024: Down 42%
  • 2023: Up 65%
  • 2022: Up 17%
Hongbo Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Hongbo Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 19 Interns 2 Part-time 1 Master's 27 Doctorate 15
Note: How fast is hiring at Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. growing? Hongbo Pharmaceutical2026: 161 openings (up 27%), 2025: 127 openings (up 22%), 2024: 104 openings (down 42%), 2023: 180 openings (up 65%), 2022: 109 openings (up 17%), 2021: 93 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Hongbo Pharmaceutical Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. growing? . Hongbo Pharmaceutical master talent ranking in Shanghai: #170, Hongbo Pharmaceutical master salary mostly around 20-50K.

Hongbo Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
+188%
Growth Rate
2026 vs 2025
  • 2025: Down 38%
  • 2024: Down 41%
  • 2023: Up 38%
  • 2022: Up 78%
Hongbo Pharmaceutical Doctoral Hiring by Year: 2026 — 15 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. growing? Hongbo PharmaceuticalDoctorate recruitment over the years: 2026: 23 openings (up 188%), 2025: 8 openings (down 38%), 2024: 13 openings (down 41%), 2023: 22 openings (up 38%), 2022: 16 openings (up 78%), 2021: 9 openings. Hongbo Pharmaceutical doctorate talent ranking in Shanghai: #45, Hongbo Pharmaceutical doctorate salary mostly around 20-50K.

Hongbo Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.? Based on an analysis of Hongbo Pharmaceutical's job postings over the past year, "Other (R&D and Technical)" demand: 39.1%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 37.6%, "Scientific Research": 36.8%, "Computer/Network/Technology": 18%, "Medical & Health/Beauty & Healthcare": 9.8%, "Mechanical/Instrumentation": 3.8%. For reference only.

Hongbo Pharmaceutical — What Are the Salaries Like? (133 records)

Manage
salary range: 4.5K - 50K, 45.1% of roles pay ¥20-50K
Note: salary statistics are based on 133 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.?Hongbo Pharmaceutical45.1% of positions earn 20-50K, Fresh graduate salary: ¥22.7K。Shanghai salary ranking top 50,其他(研发和技术类) average salary ¥17.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Hongbo Pharmaceutical

(More)
Are salaries high at Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd.? We provide: Researcher, 组长, Analyst, Chemistry, Business Development, cad, 有机合成, Information, dm, ma, MIS, PA, pi, Human Resources, Warehouse Staff, Full Stack Engineer, 实验室负责人, 库管, 药物研发, BP. Click to view detailed salary analysis by job.

Hongbo Pharmaceutical honors, qualifications & industry associations

Job Category

  • 其他(研发和技术类)
    47.3% of total 47.3%
  • 科研类
    45.1% of total 45.1%
  • 生物/制药/化工/环保类
    42.3% of total 42.3%
  • 工厂生产类
    15.4% of total 15.4%

Education

  • 本科
    42.9% of total 42.9%
  • 硕士
    26.4% of total 26.4%
  • 博士
    12.6% of total 12.6%
  • 不限
    8.8% of total 8.8%

Experience

  • 不限
    36.3% of total 36.3%
  • 1-3年
    18.1% of total 18.1%
  • 3-5年
    16.5% of total 16.5%
  • 5-10年
    15.4% of total 15.4%
View Detailed Analysis

What does Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. require? Who is Hongbo Pharmaceutical hiring? Hongbo Pharmaceutical recruitment: 其他(研发和技术类)占比最多占47.3%,其次是科研类占45.1%. What education can get in at Hongbo Pharmaceutical? 本科占比最多占42.9%,其次是硕士占26.4%. High education required at Hongbo Pharmaceutical? 硕士占26.4%,博士占12.6%. Work experience required at Hongbo Pharmaceutical? 不限占比最多占36.3%,其次是1-3年占18.1%. Where are the job locations at Hongbo Pharmaceutical? 上海占比最多占72.5%,其次是成都占26.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 18,094.1126万(元)
Legal Representative: PING CHEN
Date Established:
Credit Code: 91310000669391074C
Registered Address: 上海市浦东新区庆达路315号23幢

Partners & Suppliers

为泓博医药提供原料药及高级中间体 Source
供应商 原料药及中间体
为泓博医药提供医药中间体 Source
供应商 医药中间体
为泓博医药提供分子砌块产品 Source
供应商 分子砌块
为泓博医药提供分子砌块产品 Source
供应商 分子砌块
为泓博医药提供实验室化学试剂及耗材 Source
供应商 化学试剂

People who follow Hongbo Pharmaceutical also follow

Hongbo Pharmaceutical Competitors (Similar Companies)

“Helping partners successfully develop new drugs, reducing R&D costs an”
“To develop high-quality biologics that are accessible and affordable f”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Promoting human health”
制药/药业 医药 生物实验 原料药
V
“Health for all, vitality for life!”
“Research, development, and production of anti-tumor and surgical medic”
软膏剂 医药工业 原料药 制药/药业
“Focused on providing drug discovery services to biopharmaceutical clie”
“Global integrated biopharmaceutical enterprise”
“Innovative chemical products and services provider in the drug researc”
“Medicilon is a drug research and development outsourcing service compa”
晶圆代工 半导体 积体电路制造 生产
医药 生物医药 单克隆抗体药物 高通量筛选
“Research and development and industrialization of monoclonal antibody ”

Discover Great Companies, Discover Great Clients

上海公司名录 上海“Pudong New Area”公司名录 上海“医药”公司名录 上海“新药研发”公司名录 上海“创新药”公司名录 上海“药物研发”公司名录 上海“色谱”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates